Avivagen Inc. Announces Options Grant
OTTAWA, Ontario — Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance, announces that its Board of Directors has approved the issuance of 878,000 stock options…
Read More
0
